COMMUNIQUÉS West-GlobeNewswire

Galapagos initiates Phase 1 study with novel CF corrector GLPG3221

21/11/2017 - 22:02

Triggers a $10 million milestone payment from AbbVie Sixth clinical candidate in cystic fibrosis portfolio Mechelen, Belgium; 21 November 2017; 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announces initiation [...]

Molecular Templates to Present at the 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 22:01

AUSTIN, Texas, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new [...]

Xtant Medical Reports Third Quarter 2017 Financial Results

21/11/2017 - 21:39

Company restructuring efforts continue to gain traction towards profitability Third Quarter 2017 Highlights Reported third quarter 2017 revenue of $19.8 million compared to $23.1 million reported during the third [...]

On the 20th anniversary of Canada’s tainted blood inquiry, documents reveal the federal government worked with private pharmaceutical industry to undermine Krever’s landmark recommendations

21/11/2017 - 21:30

OTTAWA, Nov. 21, 2017 (GLOBE NEWSWIRE) -- On the eve of the 20 th anniversary of the Krever Inquiry into the tainted blood scandal, parliamentarians, health advocates and health professionals gathered in Ottawa to call [...]

480 Biomedical’s Novel Technology Featured in Nature Materials

21/11/2017 - 19:30

WATERTOWN, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- 480 Biomedical, a clinical-stage life science company committed to transforming the lives of patients with chronic diseases, announced a publication in Nature [...]

Analogic Corporation to Webcast Annual Stockholders’ Meeting

21/11/2017 - 19:30

PEABODY, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq: ALOG ), enabling the world’s medical imaging and aviation security technology, announced today that the company’s Annual Stockholders’ [...]

Bavarian Nordic Announces Exercise of Clinical Option by the US Government under Contract for Freeze-dried IMVAMUNE Smallpox Vaccine

21/11/2017 - 19:06

Award of approximately USD 37 million will support clinical work required for product approval COPENHAGEN, Denmark, November 21, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Biomedical [...]

SuperSonic Imagine to Introduce Next-Generation Aixplorer® Ultimate Ultrasound Platform at RSNA 2017

21/11/2017 - 19:00

AIX-EN-PROVENCE, France, Nov. 21, 2017 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that it will showcase the newest version [...]

Invuity Appoints Scott Flora to Board of Directors

21/11/2017 - 18:20

SAN FRANCISCO, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announced that Scott D. Flora has been appointed to its Board [...]

Abba Medix Grow Facility Improvements and MFT Advances

21/11/2017 - 18:16

TORONTO, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased to announce that its wholly-owned subsidiary, Abba Medix (“ Abba ”), has been making [...]

Ogilvy CommonHealth Worldwide Co-Publishes Primary Research Exploring In-Office Communication

21/11/2017 - 18:15

PARSIPPANY, N.J., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), the health behavior change specialists of Ogilvy & Mather ( www.ogilvy.com ) and a WPP Health & Wellness [...]

Reporting of transactions made by persons discharging managerial responsibilities in Orphazyme A/S

21/11/2017 - 17:31

Company announcement Orphazyme A/S No. 13/2017 Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 21 November 2017 Pursuant to the Market Abuse Regulation article 19, Orphazyme A/ [...]

Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Front Line Multiple Myeloma

21/11/2017 - 17:12

Company Announcement sBLA submitted to U.S. FDA for daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma ineligible for autologous stem [...]

Richardson Healthcare Announces New Preferred Replacement Parts Program and CT Service Training at RSNA 2017

21/11/2017 - 17:00

LAFOX, Ill., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Richardson Healthcare , a Division of Richardson Electronics, Ltd. (NASDAQ: RELL ), will launch its preferred partnership program, branded P3, and Philips CT service [...]

Oshkosh Physician Attends National Physicians Council for Healthcare Policy Meeting in Washington, D.C.

21/11/2017 - 15:55

TUCSON, Ariz., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Albert L. Fisher, M.D., of Oshkosh, Wisconsin, represented the Association of American Physicians and Surgeons (AAPS) at the National Physicians Council for Healthcare [...]

RESULTS FROM THE PHASE III HERCULES STUDY OF CAPLACIZUMAB FOR THE TREATMENT OF ACQUIRED TTP SELECTED FOR PRESENTATION IN THE LATE-BREAKING ABSTRACTS SESSION AT THE 2017 ASH ANNUAL MEETING

21/11/2017 - 15:41

GHENT, Belgium, 21 November 2017 (3.30pm CET) - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today announced that results from its Phase III HERCULES study of caplacizumab have been selected as one of only six [...]

Data from Phase III ALCYONE Study of Daratumumab Accepted for Oral Presentation at Annual Meeting of the American Society of Hematology

21/11/2017 - 15:34

Media Release Late-breaking abstract accepted for oral presentation Data from Phase III ALCYONE study of daratumumab in combination with bortezomib, melphalan and prednisone in front line multiple myeloma Copenhagen, [...]

Biothera Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 15:23

EAGAN, Minn., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. today announced that Chief Executive Officer Barry Labinger will present at the 29 th Annual Piper Jaffray Healthcare Conference on [...]

Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 15:15

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company focused on developing and commercializing [...]